Ye Mao

No. 1, Minde Road, Donghu District, P.R. China
Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

SERPINE2-mediated activation of JAK2/STAT3 facilitates NRF2 nuclear translocation and GCLC transcription to confer ferroptosis resistance and lenvatinib resistance in hepatocellular carcinoma.

SERPINE2-mediated activation of JAK2/STAT3 facilitates NRF2 nuclear translocation and GCLC transcription to confer ferroptosis resistance and lenvatinib resistance in hepatocellular carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 28, 2026

Current advances in immunotherapy for KRAS-Mutant pancreatic cancer.

Current advances in immunotherapy for KRAS-Mutant pancreatic cancer.

Journal: Clinical and experimental medicine

Published: February 13, 2026

Low-Dose Versus Standard-Dose Bevacizumab Plus Sintilimab for Unresectable Hepatocellular Carcinoma: A Real-World Comparative Study of Efficacy and Safety.

Low-Dose Versus Standard-Dose Bevacizumab Plus Sintilimab for Unresectable Hepatocellular Carcinoma: A Real-World Comparative Study of Efficacy and Safety.

Journal: Journal of hepatocellular carcinoma

Published: November 20, 2025

Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers.

Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers.

Journal: World journal of surgical oncology

Published: November 19, 2025

Comparative efficacy and safety of lenvatinib, sintilimab combined interventional therapy vs bevacizumab, sintilimab combined interventional therapy in intermediate and advanced hepatocellular carcinoma: a multicenter retrospective study.

Comparative efficacy and safety of lenvatinib, sintilimab combined interventional therapy vs bevacizumab, sintilimab combined interventional therapy in intermediate and advanced hepatocellular carcinoma: a multicenter retrospective study.

Journal: World journal of surgical oncology

Published: September 22, 2025

Establishment and Validation of a Novel Nutritional-Immune-Inflammatory Score Model for Predicting Survival Prognosis in Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors.

Establishment and Validation of a Novel Nutritional-Immune-Inflammatory Score Model for Predicting Survival Prognosis in Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors.

Journal: Journal of inflammation research

Published: June 11, 2025

Systematic pan-cancer analysis identifies PKNOX1 as a potential prognostic and immunological biomarker and its functional validation.

Systematic pan-cancer analysis identifies PKNOX1 as a potential prognostic and immunological biomarker and its functional validation.

Journal: Frontiers in immunology

Published: November 24, 2024

The role of ubiquitination and deubiquitination in cancer lipid metabolism.

The role of ubiquitination and deubiquitination in cancer lipid metabolism.

Journal: Frontiers in oncology

Published: July 15, 2024

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.

Journal: Cancer medicine

Published: October 01, 2023

Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study.

Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study.

Journal: Therapeutics and clinical risk management

Published: June 26, 2023

Diagnostic accuracy of circulating exosomal circRNAs in malignances: A meta-analysis and systematic review.

Diagnostic accuracy of circulating exosomal circRNAs in malignances: A meta-analysis and systematic review.

Journal: Medicine

Published: May 26, 2023

Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy.

Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy.

Journal: Open medicine (Warsaw, Poland)

Published: October 29, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026